Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment
Congcong Fang, Longqin Lv, Shanping Mao, et al.
Parkinson s Disease (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 118

Showing 26-50 of 118 citing articles:

Dopamine in the prefrontal cortex plays multiple roles in the executive function of patients with Parkinson's disease
Zihang Zhou, Yalong Yan, Heng Gu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1759-1767
Open Access | Times Cited: 11
There is ‘no cure for caregiving’: the experience of women caring for husbands living with Parkinson’s disease
Dawn R. White, Patrick A. Palmieri
International Journal of Qualitative Studies on Health and Well-Being (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Cognitive Impact of Deep Brain Stimulation in Parkinson’s Disease Patients: A Systematic Review
Valentino Rački, Mario Hero, Gloria Rožmarić, et al.
Frontiers in Human Neuroscience (2022) Vol. 16
Open Access | Times Cited: 18
Telehealth Transdiagnostic Cognitive Behavioral Therapy for Depression in Parkinson's Disease: A Pilot Randomized Controlled Trial
Ryan J. Piers, Todd J. Farchione, Bonnie Wong, et al.
Movement Disorders Clinical Practice (2022) Vol. 10, Iss. 1, pp. 79-85
Open Access | Times Cited: 16
Plasma extracellular vesicle tau, β-amyloid, and α-synuclein and the progression of Parkinson’s disease: a follow-up study
Lung Chan, Chen‐Chih Chung, Yi‐Chen Hsieh, et al.
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 10
Alleviative and Anti-Inflammatory effects of tuna blood hydrolysates on MPP+ and TNF-α - induced Parkinson-Like disease model through the regulation of Keap1-Nrf2 antioxidant pathway and apoptosis
Panlekha Rungruang, Daraphan Rodthayoy, Mantira Hawangjoo, et al.
Journal of Functional Foods (2024) Vol. 116, pp. 106134-106134
Open Access | Times Cited: 3
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools
Luca Angelini, Giulia Paparella, Matteo Bologna
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 8, pp. 799-814
Closed Access | Times Cited: 3
An Automatic Evaluation Method for Parkinson's Dyskinesia Using Finger Tapping Video for Small Samples
Zhu Li, Kang Lu, Miao Cai, et al.
Journal of Medical and Biological Engineering (2022) Vol. 42, Iss. 3, pp. 351-363
Closed Access | Times Cited: 15
Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson’s disease
Claire McGee, Ann Liebert, Geoffrey Herkes, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 15
The role of dopamine in action control: Insights from medication effects in Parkinson’s disease
Marit F. L. Ruitenberg, Nelleke C. van Wouwe, S.A. Wylie, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 158-170
Open Access | Times Cited: 18
Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
Parham Pooladgar, Mehdi Sakhabakhsh, Arsia Taghva, et al.
Deleted Journal (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 12
The importance of neuromuscular rate of force development for physical function in aging and common neurodegenerative disorders - a systematic review.
Sidsel D Lomborg, Ulrik Dalgas, Lars G. Hvid
PubMed (2022) Vol. 22, Iss. 4, pp. 562-586
Closed Access | Times Cited: 12
The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases
Francesca Bosco, Stefano Ruga, Rita Citraro, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3428-3428
Open Access | Times Cited: 7
Tau: a biomarker of Huntington’s disease
Eva Lepinay, Francesca Cicchetti
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4070-4083
Closed Access | Times Cited: 7
Immunity impacts cognitive deficits across neurological disorders
Benjamin C. Shaw, V. Anders, Rachel A. Tinkey, et al.
Journal of Neurochemistry (2023)
Open Access | Times Cited: 7
Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients
Carin Janz, Jonathan Timpka, Kristina Rosqvist, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 2, pp. 297-312
Open Access | Times Cited: 2
PINK1 knockout rats show premotor cognitive deficits measured through a complex maze
Isabel Soto, Vicki A. Nejtek, David Siderovksi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
Sreemol Gokuladhas, Tayaza Fadason, Sophie Farrow, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson’s Disease
Samuel Booth, Ji Hyun Ko
Nuclear Medicine and Molecular Imaging (2024) Vol. 58, Iss. 4, pp. 213-226
Closed Access | Times Cited: 2
PINK1 knockout rats show premotor cognitive deficits measured through a complex maze
Isabel Soto, Vicki A. Nejtek, David P. Siderovski, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Machine learning for predicting cognitive decline within five years in Parkinson’s disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers
Arman Gorji, Ali Fathi Jouzdani
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0304355-e0304355
Open Access | Times Cited: 2
Parkinsonism and dementia
Christos Koros, Leonidas Stefanis, Nikolaos Scarmeas
Journal of the Neurological Sciences (2021) Vol. 433, pp. 120015-120015
Closed Access | Times Cited: 16
Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study
Antonina Luca, Roberto Monastero, Calogero Edoardo Cicero, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 3, pp. 287-293
Open Access | Times Cited: 11
Neural synchronization analysis of electroencephalography coherence in patients with Parkinson’s disease-related mild cognitive impairment
Tomoo Mano, Kaoru Kinugawa, Maki Ozaki, et al.
Clinical Parkinsonism & Related Disorders (2022) Vol. 6, pp. 100140-100140
Open Access | Times Cited: 11
Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer’s Disease, Parkinson’s Disease, or Frontotemporal Dementia: Implications for Patient Survival
Mohammad Golam Sabbir, Robert C. Speth, Benedict C. Albensi
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 2, pp. 727-747
Closed Access | Times Cited: 11

Scroll to top